Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
United Kingdom

Cambridge Innovation Capital

Investment focus

Sectors

Life Sciences
Deeptech
AI

Investment stages

Seed
Series A
Series B

Geographic focus

United Kingdom

Investment thesis

University of Cambridge-affiliated VC commercialising world-class science and deep tech spinouts from the Cambridge ecosystem, with expertise in life sciences and frontier technology.

Typical check size

€1M – €15M

Fund size: ~£600M AUM (Opportunity Fund £100M, 2025)

Browse similar check sizes →

Portfolio highlights

Gyroscope Therapeutics - gene therapy (acquired by Novartis for $1.5B)
Pragmatic Semiconductor - flexible electronics
Riverlane - quantum error correction (raised £75M+, partnered with Google and Intel)

Contact

cic.vc
United Kingdom

Research with AI

Learn more about Cambridge Innovation Capital using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Cambridge Innovation Capital and similar investors look for:

AI pitch guide

More investors in United Kingdom

20VC21506 Degrees Capital83NorthView all in United Kingdom

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideGlossary: Term sheet
Fundraising in United Kingdom

Tips, programs, and cultural notes

More Life Sciences investors

Boehringer Ingelheim Venture FundBritish Patient CapitalEIFOEnterprise IrelandView all Life Sciences investors